Home›Research›Compare›CJC-1295 vs Liraglutide
Peptide Comparison
CJC-1295 vs Liraglutide
Both are Fat Loss peptides.
CJC-1295
CJC-1295 DAC
Half-life: 6–8 days (DAC form)
429 providers listed
Liraglutide
Victoza
Half-life: 13 hours
46 providers listed
Quick Verdict
CJC-1295
Risk
Half-life
6–8 days (DAC form)
Liraglutide
Risk
Half-life
13 hours
Side-by-Side Comparison
About CJC-1295
CJC-1295 binds to and activates pituitary GHRH receptors, stimulating pulsatile GH secretion. The DAC modification enables covalent binding to albumin, dramatically extending the active peptide half-life. This sustained GH pulse pattern is intended to mimic physiological GH release more closely than shorter-acting GHRH analogues.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) form binds to albumin in the bloodstream, extending its half-life to several days and enabling sustained elevation of GH and IGF-1 levels. It is commonly researched alongside GHRP peptides for body composition and recovery outcomes.
Research Areas
About Liraglutide
GLP-1 receptor agonist; slows gastric emptying, increases satiety, reduces glucagon secretion
A GLP-1 receptor agonist used for weight management and type 2 diabetes. Reduces appetite and promotes significant fat loss.
Research Areas
Find Providers
Where to source these peptides
Providers offering
CJC-1295
429 listed
Browse directory →
Providers offering
Liraglutide
46 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.